Type 2 & other diabetes

Nonlinear association between atherogenic index of plasma and type 2 diabetes mellitus in overweight and obesity patients: evidence from Chinese medical examination data

Cardiovasc DiabetolPublished Cross-sectional study

Main finding · T2DM risk per AIP (adjusted)Result — go to the resultOdds ratio 3.18 95% CI 2.94–3.45

Authors' conclusion

In overweight and obese individuals, the AIP was independently associated with T2DM, exhibiting a nonlinear association. Additionally, the association between the AIP and T2DM decreased with advancing age. Multiple types of inflammatory cells mediate this association.

Study context

Population
Overweight and obese individuals (body mass index (BMI) ≥ 24 kg/m²) screened January 2018 to December 2023 at Henan Provincial People's Hospital
Participants
40,633 participants
Exposure
Atherogenic index of plasma (AIP) levels and T2DM in overweight and obese individuals
Outcome
Association between AIP and T2DM
Methodological detailssingle-centre medical examination data, multivariate logistic regression, generalized additive models, threshold effect analysis, mediation analysis
  • Single-centre medical examination data
  • Multivariate logistic regression
  • Generalized additive models
  • Threshold effect analysis
  • Mediation analysis

Main finding

T2DM risk per AIP (adjusted)

Odds ratio

3.18

95% CI 2.94–3.45

Q4vs Q1
OR 3.18 (95% CI 2.94–3.45)

As reported in the abstract

AIP associated with T2DM risk after adjustment, OR
5.17 (95% CI 4.69-5.69)

Observational data: associations, not effects.

Further findings

Subgroup by age

Association between AIP and T2DM decreased with increasing age
interaction P < 0.001

Nonlinear pattern

J-shaped nonlinear association; significant increase in T2DM risk above AIP threshold
AIP > - 0.07

Mediation by inflammatory cells

Neutrophils mediated
4.66%
Leukocytes mediated
4.16%
Monocytes mediated
1.93%

Original publication

Nonlinear association between atherogenic index of plasma and type 2 diabetes mellitus in overweight and obesity patients: evidence from Chinese medical examination data. Cardiovasc Diabetol. Published 29 June 2024. doi:10.1186/s12933-024-02330-y

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.